Intelligence Platform

Patents

Browse 369 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6903070

Glycopeptide carboxy-saccharide derivatives

Theravance, Inc. · Granted Tue Jun 07 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6897305

Calcium channel drugs and uses

Theravance, Inc. · Granted Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6887866

Short-acting sedative hypnotic agents for anesthesia and sedation

Theravance, Inc. · Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6887976

Glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue May 03 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6878686

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6872701

Glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6872741

Sodium channel modulators

Theravance, Inc. · Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6872804

Glycopeptide disulfide and thioester derivatives

Theravance, Inc. · Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6858584

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

Theravance, Inc. · Granted Tue Feb 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6831150

Reductive alkylation process

Theravance, Inc. · Granted Tue Dec 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6828299

Polyhydroxy glycopeptide derivatives

Theravance, Inc. · Granted Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6815555

Substituted phenol compounds useful for anesthesia and sedation

Theravance, Inc. · Granted Tue Nov 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6770621

Polyacid glycopeptide derivatives

Theravance, Inc. · Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6756400

Sodium channel modulators

Theravance, Inc. · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6750241

Protein kinase inhibitors

Theravance, Inc. · Granted Tue Jun 15 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6747043

Alkoxy aryl &bgr;2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6693202

Muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6686362

Indolinone derivatives

Theravance, Inc. · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6670376

Aryl aniline &bgr;2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6653323

Aryl aniline &bgr;2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6646012

Sodium channel modulators

Theravance, Inc. · Granted Tue Nov 11 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6635618

Glycopeptide phosphonate derivatives

Theravance, Inc. · Granted Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6635764

Therapeutic ureas

Theravance, Inc. · Granted Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6620781

Glycopeptide carboxy-saccharide derivatives

Theravance, Inc. · Granted Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired